Medicare Enrolled

Dr. David Chappell, M.D.

Endocrinology · Petaluma, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
141 LYNCH CREEK WAY, Petaluma, CA 94954
7077620001
In practice since 2006 (20 years)
NPI: 1598732463 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chappell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chappell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chappell

Dr. David Chappell is an endocrinology specialist in Petaluma, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chappell performed 1,907 Medicare services across 520 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chappell received a total of $20,485 from 51 pharmaceutical and/or device companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chappell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 30% volume in CA $20,485 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,907
Medicare services
Top 30% in CA for endocrinology
520
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
678 $77 $124
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
449 $104 $228
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
289 $8 $22
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
245 $3 $4
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
61 $12 $76
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
47 $143 $241
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
35 $28 $62
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
29 $44 $212
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
23 $3 $10
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $47 $108
New patient office visit, complex (60-74 min) 16 $166 $380
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
15 $10 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,485
Total received (2018-2024)
Avg $2,926/year across 7 years
Top 12% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
606
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,588 (56.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,243 (40.2%)
Other
Charitable contributions, space rental, and other categories
$654 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,791
2023
$1,357
2022
$1,699
2021
$2,400
2020
$1,231
2019
$1,201
2018
$10,807

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$545
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
PFIZER INC.
$142
ABBVIE INC.
$139
Astellas Pharma US Inc
$132
Xeris Pharmaceuticals, Inc.
$107
Novo Nordisk Inc
$97
Bayer Healthcare Pharmaceuticals Inc.
$85
Amgen Inc.
$79
Radius Health, Inc.
$63
Lexicon Pharmaceuticals, Inc.
$58
Dexcom, Inc.
$48
Acella Pharmaceuticals, LLC
$48
Abbott Laboratories
$28
Alexion Pharmaceuticals, Inc.
$27
Corcept Therapeutics
$21
Tandem Diabetes Care, Inc.
$18
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$8,673
Lilly USA, LLC
$1,674
Novo Nordisk Inc
$1,213
Medtronic MiniMed, Inc.
$1,166
Radius Health, Inc.
$1,067
Boehringer Ingelheim Pharmaceuticals, Inc.
$819
Amgen Inc.
$698
AbbVie Inc.
$624
Welch Allyn
$436
SANOFI-AVENTIS U.S. LLC
$411
ABBVIE INC.
$354
AbbVie, Inc.
$248
Amarin Pharma Inc.
$239
Baxter Healthcare
$218
MannKind Corporation
$218
Xeris Pharmaceuticals, Inc.
$172
PFIZER INC.
$142
Bayer Healthcare Pharmaceuticals Inc.
$134
Astellas Pharma US Inc
$132
Insulet Corporation
$130
Biohaven Pharmaceuticals, Inc.
$124
Merck Sharp & Dohme Corporation
$116
Corcept Therapeutics
$116
Alexion Pharmaceuticals, Inc.
$115
Horizon Therapeutics plc
$108
Shire North American Group Inc
$99
Mannkind Corporation
$90
Bayer HealthCare Pharmaceuticals Inc.
$90
Nestle HealthCare Nutrition Inc.
$89
Janssen Pharmaceuticals, Inc
$74
Allergan, Inc.
$65
Lexicon Pharmaceuticals, Inc.
$58
Dexcom, Inc.
$48
Acella Pharmaceuticals, LLC
$48
Abbott Laboratories
$47
Ultragenyx Pharmaceutical Inc.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$45
Tandem Diabetes Care, Inc.
$44
VIVUS, Inc.
$41
Bigfoot Biomedical Inc
$30
Merz North America, Inc.
$27
Kyowa Kirin, Inc.
$26
VIVUS LLC
$23
Janssen Scientific Affairs, LLC
$22
Medtronic, Inc.
$21
Ferring Pharmaceuticals Inc.
$21
CeQur Corporation
$20
Allergan Inc.
$19
Teva Pharmaceuticals USA, Inc.
$16
Galderma Laboratories, L.P.
$15
Zealand Pharma US, Inc.
$15
Top 3 companies account for 56.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AirDuo Digihaler · BAQSIMI · BOTOX · BOTOX COSMETIC · CREON · CRYSViTA · CeQur Simplicity · Creon · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LYUMJEV · MINIMED 770G · MOUNJARO · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NP Thyroid 60 · NURTEC ODT · None · Omnipod · Ozempic · PNEUMOVAX 23 · Prolia · QSYMIA · QTERN · QULIPTA · RECORLEV · RETEVMO · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tymlos · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · V-GO DISPOSABLE INSULIN DELIVERY · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XEOMIN · ZENPEP · ZOMACTON · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Petaluma?
Compare endocrinologists in the Petaluma area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
23
Per 100K population
4.7
County median income
$102,840
Nearest hospital
PETALUMA VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chappell is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chappell experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Chappell performed 678 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chappell receive payments from pharmaceutical companies?
Yes. Dr. Chappell received a total of $20,485 from 51 companies across 606 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chappell's costs compare to other endocrinologists in Petaluma?
Dr. Chappell's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chappell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →